Preventing Maternal Deaths: Supporting Maternal Mortality Review Committees

 

This funding will support existing Maternal Mortality Review Committees to identify and characterize maternal deaths for identifying prevention opportunities. Awardees will identify pregnancy-associated deaths within one year of death; abstract and enter clinical and non-clinical data into a standard data system [Maternal Mortality Review Information Application (MMRIA)], conduct multidisciplinary reviews, and enter committee decisions in MMRIA within 2 years of death. Quality assurance processes, in partnership with CDC, will be used for improving data quality, completeness, and timeliness. Awardees will analyze data and share findings with stakeholders to inform policy and prevention strategies to reduce maternal deaths. This funding will support existing Maternal Mortality Review Committees to identify and characterize maternal deaths for identifying prevention opportunities. Awardees will identify pregnancy-associated deaths; abstract clinical and non-clinical data into a standard data system (MMRIA); conduct multidisciplinary reviews; and enter committee decisions into MMRIA. Awardees will use quality assurance processes, in partnership with CDC, to improve data quality and timeliness. Awardees will analyze data and share findings with stakeholders to inform policy and prevention strategies that reduce maternal deaths.

Active 93.478 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. To support States in their work to save and sustain the health of mothers during pregnancy, childbirth, and in the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths and for other purposes., Title Maternal Health Accountability Act of 2017, Part (d) MATERNAL MORTALITY REVIEW COMMITTEES, Section SEC. 2. SAFE MOTHERHOOD
Public Health Service Act, Section 301(a) and 317K, 42 U.S.C. 241(a); 42 U.S.C. 247b-12 Not applicable. Not applicable. This funding opportunity has special eligibility requirements of applicants. If evidence of these eligibility requirements are not included with the application, the application is deemed non-responsive. o AUTHORITIES AND PROTECTIONS. Applicants must submit evidence, by submitting copies or through reference to specific statutes, rules, or legislation that provides the MMRC: o Authority to access clinical and non-clinical records o Protection of data collected, proceedings, and activities o Immunity for committee members from subpoena related to maternal deaths they reviewed as members of the MMRC o HAVE AN EXISTING POPULATION-BASED MATERNAL MORTALITY REVIEW COMMITTEE ACTIVELY REVIEWING DEATHS AT THE TIME OF APPLICATION. The purpose of this funding opportunity is to support existing MMRCs rather than the establishment of new MMRCs. Applicants must submit evidence that they are an active MMRC. Examples of evidence include dated products of MMRC meetings, such as a meeting agenda, meeting notifications to committee members, or a schedule of meeting dates and locations from the preceding 12 months. o VITAL RECORDS ACCESS. Death certificates that can be matched with birth and fetal death certificates form the foundation for identifying pregnancy-associated deaths. The applicant must provide evidence that they have access to identified data from these three vital records files. Evidence includes a Memorandum of Understanding (MOU), a Memorandum of Agreement (MOA), Data Use Agreement (DUA), or Letter of Support from the vital records registrar's office that confirms access to this data by the applicant. o ABILITY TO SHARE MMRIA DATA WITH CDC. There are 3 core purposes of the funding opportunity that are dependent on awardees sharing their MMRIA data with CDC: o Timely identification of data quality problems o Timely identification of awardee technical assistance needs o Analyses of data across awardees by CDC to characterize maternal deaths and to identify opportunities for prevention Evidence of the ability to share MMRIA data with CDC would be documentation of experience sharing similar limited identified data with CDC, or a letter from the applicant's legal authority documenting the ability of the applicant to share MMRIA data with CDC. Preapplication coordination is not applicable. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Applications will be submitted via grants.gov as specified in the NOFO. All applications submitted by the deadline that are complete and responsive to the NOFO will undergo an objective review process, receive a written critique and be scored according to published review criteria. Successful applicants will receive a Notice of Award from the CDC Office of Financial Resources. The Notice of Award shall be the only binding, authorizing document between the recipient and CDC and will be signed by an authorized CDC Grants Management Officer. Contact the headquarters or regional location, as appropriate for application deadlines From 60 to 90 days. Not applicable. More than 180 days. The project period is 5-years with 12-month budget periods. Throughout the project period, CDC's commitment to continuation of awards will be conditioned on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports, in documented technical assistance, and in other relevant documented activities) and the determination that continued funding is in the best interest of the federal government. Phase I: All applications will be initially reviewed for eligibility and completeness by CDC Office of Grants Services. Complete applications will be reviewed for responsiveness by the Grants Management Officials and Program Officials. Non-responsive applications will not advance to Phase II review. Applicants will be notified that their applications did not meet eligibility and/or published submission requirements. Phase II: Responsive applications go through an objective merit review process that evaluates complete, eligible applications using criteria aligned with the three broad sections described earlier in the NOFO: o Approach o Evaluation and Performance Measurement o Applicant's Organizational Capacity to Implement the Approach Phase III Review: Applications submitted under will be funded by score and rank as determined by the objective review panel. The Selecting official shall rely on the rank order established by the objective review panel as the primary factor in making awards. However, there may be exceptions to this process that may affect the final funding decision, e.g., risk, geographic diversity, and racial and ethnic diversity. Funds can be used to support core MMRC functions (i.e. abstraction, analysis, coordination, meeting logistics, dissemination activities, and travel for annual reverse site visit). Funds can be used to pay for activities and supplies necessary to conduct the aims outlined here. Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award. Not applicable. In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Funding for this program will be awarded on annual basis and the funding will be available for obligation by recipients for a period of 12-months. Notice of Award None/Not specified. Sheryl Heard
4770 Buford Highway, NE
Atlanta, GA 30341 USA
slh3@cdc.gov
Phone: 770-488-2855 75-0943-0-1-550 (Cooperative Agreements) FY 22$11,170,723.00; FY 23 est $15,160,723.00; FY 24 est $15,160,723.00; FY 21$11,170,723.00; FY 20$9,075,548.00; FY 19$9,074,548.00; FY 18$0.00; FY 17$0.00; - Awards are expected to range from $150,000 to $600,000 per year. N/A Not applicable.